Bli Banque De Luxembourg Investments Gilead Sciences, Inc. Transaction History
Bli Banque De Luxembourg Investments
- $3.68 Trillion
- Q4 2024
A detailed history of Bli Banque De Luxembourg Investments transactions in Gilead Sciences, Inc. stock. As of the latest transaction made, Bli Banque De Luxembourg Investments holds 25,031 shares of GILD stock, worth $2.61 Million. This represents 0.06% of its overall portfolio holdings.
Number of Shares
25,031Holding current value
$2.61 Million% of portfolio
0.06%Shares
1 transactions
Others Institutions Holding GILD
# of Institutions
2,072Shares Held
1.02BCall Options Held
9.63MPut Options Held
10.2M-
Black Rock Inc. New York, NY121MShares$12.6 Billion0.19% of portfolio
-
Vanguard Group Inc Valley Forge, PA116MShares$12 Billion0.19% of portfolio
-
Capital World Investors Los Angeles, CA71.7MShares$7.46 Billion1.05% of portfolio
-
State Street Corp Boston, MA60.4MShares$6.28 Billion0.23% of portfolio
-
Capital Research Global Investors Los Angeles, CA57.9MShares$6.03 Billion1.15% of portfolio
About GILEAD SCIENCES, INC.
- Ticker GILD
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 1,253,369,984
- Market Cap $130B
- Description
- Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...